The MarketWatch News Department was not involved in the creation of this content. Repertoire and Pioneering Medicines, Flagship's in-house drug development unit, will jointly conduct research ...

AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record net ...

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

Pfizer Inc. (NYSE:PFE) ranks among the top picks for a retirement portfolio. BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on September 23 in response to ...

Pfizer is seeking drug development partnerships with Chinese biotech companies as local players gain ground on Western peers.

Pfizer is selling its remaining stake in COVID-19 vaccine partner BioNTech. The U.S. drugmaker is offering about 4.55 million American depositary receipts in an overnight block trade, marketed at ...

Pharmaceutical companies AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, ...

President Donald Trump announced a partnership with Pfizer in hopes of bringing down the cost of prescription drug prices. He said other drug makers will follow suit, and if they don't they could face ...

The U.S. FDA on Tuesday granted traditional approval for a first-line combination regimen involving Braftovi, an oral cancer drug developed by Pfizer (PFE) in partnership with companies such as ...

The drugmaker reported revenue that fell from a year ago amid slumping sales of COVID vaccines and treatments, but still topped expectations Pfizer's buyout bid for Metsera was deemed inferior to the ...

Repertoire and Pioneering Medicines, Flagship's in-house drug development unit, will jointly conduct research activities leveraging Repertoire's DECODE™ platform CAMBRIDGE, Mass., Dec. 22, 2025 ...